Reshma Shetty
Dr. Reshma Shetty is a co-founder, COO and President of Ginkgo Bioworks which recently listed on the New York Stock Exchange under the ticker symbol $DNA. Ginkgo’s mission is to make biology easier to engineer. Under her leadership, Ginkgo has grown into the premiere platform company for engineering biology and is playing a crucial role in the global response to COVID-19.
Reshma has been active in the field of synthetic biology for nearly 20 years, co-organizing the first international conference in the field in 2004. In 2008, Forbes magazine named Reshma one of Eight People Inventing the Future and in 2011, Fast Company named her one of 100 Most Creative People in Business. In 2014, Ginkgo became the first biotech company to participate in YCombinator.
In 2018, Business Insider named her one of the most powerful female engineers. In 2019, BIO recognized Reshma with the Rosalind Franklin Award for Leadership in Industrial Biotechnology and Agriculture. Reshma Shetty has a B.S. degree in Computer Science from the University of Utah and a Ph.D. in Biological Engineering from MIT.
Since 2022, Reshma has been a member of the U.S. Department of Defense’s Defense Science Board.